Company / Current Liabilities
Merck & Co. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$28.3B
FY2025
5-year range
$23.9B / $28.4B
FY2021-FY2025
Trend
-0.3%
vs FY2024
Sector context
#5 of 213
Health Care
What the data says
Among 213 Health Care companies, Merck & Co. is in the bottom 2% for current liabilities. Current Liabilities has fluctuated over the past 10 years, ranging from $17.2B in FY2016 to $28.4B in FY2024.
Based on SEC 10-K filings.
$28.3B in FY2025 with a 5-year CAGR of +0.7%. Top quartile in the Health Care sector.
Increased from $25.7B to $28.3B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- +0.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 213This company $28.3B Sector average $1.6B
▼
+1683.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.7%, indicating consistent growth.
- In FY2025, current liabilities decreased 0.3% year-over-year.
- Ranks #5 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.3B | -0.3% |
| FY2024 | $28.4B | +10.6% |
| FY2023 | $25.7B | +6.0% |
| FY2022 | $24.2B | +1.5% |
| FY2021 | $23.9B | -12.6% |
| FY2020 | $27.3B | +23.0% |
| FY2019 | $22.2B | +0.1% |
| FY2018 | $22.2B | +19.3% |
| FY2017 | $18.6B | +8.2% |
| FY2016 | $17.2B | -10.4% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026